Pay in 4 interest-free payments of $5.75 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Side-by-side comparison Factor Receptor targets Semaglutide GLP-1 only Tirzepatide GLP-1 + GIP Retatrutide GLP-1 + GIP + glucagon Liraglutide GLP-1 only Factor Half-life Semaglutide ~7 days Tirzepatide ~5 days Retatrutide ~6 days Liraglutide ~13 hours Factor Dosing frequency Semaglutide Once weekly Tirzepatide Once weekly Retatrutide Once weekly Liraglutide Once daily Factor Max studied dose Semaglutide 2.4 mg/week (SubQ)
Occasional, moderate drinking has a smaller impact but still contributes to slower progress compared to abstaining
Clinical Evidence on Post-Treatment Weight Gain The SURMOUNT trial, which evaluated tirzepatide's long-term effects, tracked patients after they stopped treatment
Understanding its definition and purpose helps women recognize its potential role in their health journey, particularly in achieving sustainable weight loss
US$ 21.86
US$ 25.97
US$ 20.80
